SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-172959
Filing Date
2022-06-13
Accepted
2022-06-13 16:34:07
Documents
17
Period of Report
2022-06-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d355833d8k.htm   iXBRL 8-K 40808
2 EX-10.1 d355833dex101.htm EX-10.1 365255
3 EX-10.2 d355833dex102.htm EX-10.2 144459
4 EX-99.1 d355833dex991.htm EX-99.1 12334
9 GRAPHIC g355833g94e00.jpg GRAPHIC 15627
  Complete submission text file 0001193125-22-172959.txt   852978

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20220608.xsd EX-101.SCH 3942
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20220608_def.xml EX-101.DEF 13312
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20220608_lab.xml EX-101.LAB 21933
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20220608_pre.xml EX-101.PRE 14209
11 EXTRACTED XBRL INSTANCE DOCUMENT d355833d8k_htm.xml XML 5630
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 221012093
SIC: 2836 Biological Products, (No Diagnostic Substances)